Loading asset research
Q3 2026 earnings · Sep 21
PharmaCyte Biotech Inc. Common Stock
PMCBNasdaq · USD · StocksQuote as of · Exchange session not verified$0.4636
+4.82%
Today
PMCB
Loading 1D prices…
Market cap
$4.8M
Volume
48.5K
52w high
$1.5152w low
$0.4302Company profile
PharmaCyte Biotech Inc. Common Stock
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Las Vegas, NV, United States
Employees
2
Fiscal year end
0430
CIK
1157075
Session & valuation
Open$0.4403
Previous close$0.4423
Day high$0.468
Day low$0.4302
30-day avg. volume97.4K
Outstanding shares10.7M
Diluted EPS-$2.77
Latest annual period
P/E (trailing)-0.17
P/E (forward)-1.18
Price / book0.14
Beta0.66
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LIMNLiminatus Pharma Inc. Class A Common Stock | $4.7M | $0.00 | — | -$0.43 | -4.41% | Unrated |
| VIVSVivoSim Labs Inc. Common Stock | $3.8M | $131K | -10567.18% | -$5.35 | -6.67% | Unrated |
| CELZCreative Medical Technology Holdings Inc. Common Stock | $6.3M | $6K | -99916.80% | -$2.52 | +1.09% | Buy |
| CLDICalidi Biotherapeutics Inc. Common Stock | $3.2M | $0.00 | — | -$5.95 | -5.34% | Unrated |
| AIMAIM ImmunoTech Inc. Common Stock | $8.3M | $88K | -15861.36% | -$8.62 | -2.65% | Buy |